Fibroblast growth factor-2 and bone morphogenetic protein-2 have a synergistic stimulatory effect on bone formation in cell cultures from elderly mouse and human bone

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 68, Issue 10, 2013, Pages 1170-1180

  Kuhn, Liisa T ^a   Ou, Guomin ^a,b   Charles, Lyndon ^a   Hurley, Marja M ^a   Rodner, Craig M ^a   Gronowicz, Gloria ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b SICHUAN UNIVERSITY   (China)

Author keywords

Aging; Bones; Stem cells.

Indexed keywords

BMP2 PROTEIN, HUMAN; BONE MORPHOGENETIC PROTEIN 2; FIBROBLAST GROWTH FACTOR 2; RECOMBINANT PROTEIN;

ADULT; AGED; AGING; ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BONE DEVELOPMENT; BONE MINERALIZATION; BONES; CELL CULTURE; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; DRUG POTENTIATION; FEMALE; HUMAN; MESENCHYMAL STROMA CELL; MIDDLE AGED; MOUSE; OSTEOBLAST; PATHOLOGY; STEM CELLS.; TRANSGENIC MOUSE; YOUNG ADULT; DRUG EFFECTS;

AGING; BONES; STEM CELLS.;

ADULT; AGED; AGING; ANIMALS; BONE MORPHOGENETIC PROTEIN 2; CALCIFICATION, PHYSIOLOGIC; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; FEMALE; FIBROBLAST GROWTH FACTOR 2; HUMANS; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; MIDDLE AGED; OSTEOBLASTS; OSTEOGENESIS; RECOMBINANT PROTEINS; YOUNG ADULT;

EID: 84884992545     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/glt018     Document Type: Article

References (42)

1. Stolzing A, Jones E, McGonagle D, Scutt A. Age-related changes in human bone marrow-derived mesenchymal stem cells: consequences for cell therapies. Mech Ageing Dev. 2008;129:163-173.
2. Muschler GF, Nitto H, Boehm CA, Easley KA. Age- and genderrelated changes in the cellularity of human bone marrow and the prevalence of osteoblastic progenitors. J Orthop Res. 2001;19:117-125. (Pubitemid 32288644)
3. Zhang H, Lewis CG, Aronow MS, Gronowicz GA. The effects of patient age on human osteoblasts' response to Ti-6Al-4V implants in vitro. J Orthop Res. 2004;22:30-38. (Pubitemid 38035442)
4. Justesen J, Stenderup K, Eriksen EF, Kassem M. Maintenance of osteoblastic and adipocytic differentiation potential with age and osteoporosis in human marrow stromal cell cultures. Calcif Tissue Int. 2002;71:36-44. (Pubitemid 36934774)
5. Yamaguchi A, Katagiri T, Ikeda T, et al. Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro. J Cell Biol. 1991;113:681-687. (Pubitemid 21926024)
6. Dickinson BP, Ashley RK, Wasson KL, et al. Reduced morbidity and improved healing with bone morphogenic protein-2 in older patients with alveolar cleft defects. Plast Reconstr Surg. 2008;121:209-217.
7. Boyne PJ, Marx RE, Nevins M, et al. A feasibility study evaluating rhBMP-2/absorbable collagen sponge for maxillary sinus floor augmentation. Int J Periodontics Restorative Dent. 1997;17:125-139.
8. Howard G, Bottemiller B, Baylink D. Evidence for the coupling of bone formation to bone resorption in vivo. Metab Bone Dis Rel Res. 1980;2:131-135.
9. Zebboudj AF, Shin V, Boström K. Matrix GLA protein and BMP-2 regulate osteoinduction in calcifying vascular cells. J Cell Biochem. 2003;90:756-765. (Pubitemid 37392466)
10. Kleeff J, Maruyama H, Ishiwata T, et al. Bone morphogenetic protein 2 exerts diverse effects on cell growth in vitro and is expressed in human pancreatic cancer in vivo. Gastroenterology. 1999;116:1202-1216. (Pubitemid 29203031)
11. Fleet JC, Cashman K, Cox K, Rosen V. The effects of aging on the bone inductive activity of recombinant human bone morphogenetic protein-2. Endocrinology. 1996;137:4605-4610. (Pubitemid 26403295)
12. Pri-Chen S, Pitaru S, Lokiec F, Savion N. Basic fibroblast growth factor enhances the growth and expression of the osteogenic phenotype of dexamethasone-treated human bone marrow-derived bone-like cells in culture. Bone. 1998;23:111-117. (Pubitemid 28379871)
13. Berrada S, Lefebvre F, Harmand MF. The effect of recombinant human basic fibroblast growth factor rhFGF-2 on human osteoblast in growth and phenotype expression. In Vitro Cell Dev Biol Anim. 1995;31:698-702.
14. Canalis E, Centrella M, McCarthy T. Effects of basic fibroblast growth factor on bone formation in vitro. J Clin Invest. 1988;81:1572-1577.
15. Kawaguchi H, Nakamura K, Tabata Y, et al. Acceleration of fracture healing in nonhuman primates by fibroblast growth factor-2. J Clin Endocrinol Metab. 2001;86:875-880. (Pubitemid 32207509)
16. Mayahara H, Ito T, Nagai H, et al. In vivo stimulation of endosteal bone formation by basic fibroblast growth factor in rats. Growth Factors. 1993;9:73-80. (Pubitemid 23241843)
17. Dunstan CR, Boyce R, Boyce BF, et al. Systemic administration of acidic fibroblast growth factor (FGF-1) prevents bone loss and increases new bone formation in ovariectomized rats. J Bone Miner Res. 1999;14:953-959. (Pubitemid 29262890)
18. Hurley MM, Abreu C, Gronowicz G, Kawaguchi H, Lorenzo J. Expression and regulation of basic fibroblast growth factor mRNA levels in mouse osteoblastic MC3T3-E1 cells. J Biol Chem. 1994;269:9392-9396. (Pubitemid 24209272)
19. Hurley MM, Kessler M, Gronowicz G, Raisz LG. The interaction of heparin and basic fibroblast growth factor on collagen synthesis in 21-day fetal rat calvariae. Endocrinology. 1992;130:2675-2682.
20. Hurley MM, Florkiewicz R. Fibroblast growth factor and vascular endothelial fibroblast growth factor families. In: Bilezikian J, Raisz LG, Rodan G, eds. Principles of Bone Biology. 1st ed. San Diego, CA: Academic Press; 1996;27-645.
21. McCarthy TL, Centrella M, Canalis E. Effects of fibroblast growth factors on deoxyribonucleic acid and collagen synthesis in rat parietal bone cells. Endocrinology. 1989;125:2118-2126. (Pubitemid 19258650)
22. Ou G, Charles L, Matton S, et al. Fibroblast growth factor-2 stimulates the proliferation of mesenchyme-derived progenitor cells from aging mouse and human bone. J Gerontol A Biol Sci Med Sci. 2010;65:1051-1059.
23. Montero A, Okada Y, Tomita M, et al. Disruption of the fibroblast growth factor-2 gene results in mice results in decreased bone mass and bone formation. J Clin Invest. 2000;105:1085-1093. (Pubitemid 30217693)
24. N aganawa T, Xiao L, Coffin JD, et al. Reduced expression and function of bone morphogenetic protein-2 in bones of Fgf2 null mice. J Cell Biochem. 2008;103:1975-1988. (Pubitemid 351501926)
25. Hanada K, Dennis JE, Caplan AI. Stimulatory effects of basic fibroblast growth factor and bone morphogenetic protein-2 on osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells. J Bone Miner Res. 1997;12:1606-1614. (Pubitemid 27422361)
26. Maegawa N, Kawamura K, Hirose M, Yajima H, Takakura Y, Ohgushi H. Enhancement of osteoblastic differentiation of mesenchymal stromal cells cultured by selective combination of bone morphogenetic protein-2 (BMP-2) and fibroblast growth factor-2 (FGF-2). J Tissue Eng Regen Med. 2007;1:306-313.
27. Kotev-Emeth S, Savion N, Pri-chen S, Pitaru S. Effect of maturation on the osteogenic response of cultured stromal bone marrow cells to basic fibroblast growth factor. Bone. 2000;27:777-783.
28. Varkey M, Kucharski C, Haque T, Sebald W, Uluda? H. In vitro osteogenic response of rat bone marrow cells to bFGF and BMP-2 treatments. Clin Orthop Relat Res. 2006;443:113-123. (Pubitemid 44324941)
29. Zhang H, Aronow MS, Gronowicz GA. Transforming growth factorbeta 1 (TGF-beta1) prevents the age-dependent decrease in bone formation in human osteoblast/implant cultures. J Biomed Mater Res A. 2005;75:98-105. (Pubitemid 41298191)
30. Jorgensen NR, Henriksen Z, Sorensen OH, Civitelli R. Dexamethasone, BMP-2, and 1,25-dihydroxyvitamin D enhance a more differentiated osteoblast phenotype: validation of an in vitro model for human bone marrow-derived primary osteoblasts. Steroids. 2004;69:219-226. (Pubitemid 38748717)
31. Fakhry A, Ratisoontorn C, Vedhachalam C, et al. Effects of FGF-2/-9 in calvarial bone cell cultures: differentiation stage-dependent mitogenic effect, inverse regulation of BMP-2 and noggin, and enhancement of osteogenic potential. Bone. 2005;36:254-266. (Pubitemid 40283582)
32. Sachse A, Wagner A, Keller M, et al. Osteointegration of hydroxyapatite- titanium implants coated with nonglycosylated recombinant human bone morphogenetic protein-2 (BMP-2) in aged sheep. Bone. 2005;37:699-710. (Pubitemid 41476393)
33. Kalajzic I, Kalajzic Z, Kaliterna M, et al. Use of type I collagen green fluorescent protein transgenes to identify subpopulations of cells at different stages of the osteoblast lineage. J Bone Miner Res. 2002;17:15-25. (Pubitemid 33150992)
34. Paic F, Igwe JC, Nori R, et al. Identification of differentially expressed genes between osteoblasts and osteocytes. Bone. 2009;45:682-692.
35. Kuhn LT, Liu Y, Advincula M, Wang YH, Maye P, Goldberg AJ. A nondestructive method for evaluating in vitro osteoblast differentiation on biomaterials using osteoblast-specific fluorescence. Tissue Eng Part C Methods. 2010;16:1357-1366.
36. Wang YH, Liu Y, Maye P, Rowe DW. Examination of mineralized nodule formation in living osteoblastic cultures using fluorescent dyes. Biotechnol Prog. 2006;22:1697-1701. (Pubitemid 44912676)
37. Zhao B, Katagiri T, Toyoda H, et al. Heparin potentiates the in vivo ectopic bone formation induced by bone morphogenetic protein-2. J Biol Chem. 2006;281:23246-23253.
38. Kalajzic I, Kalajzic Z, Hurley MM, Lichtler AC, Rowe DW. Stage specific inhibition of osteoblast lineage differentiation by FGF2 and noggin. J Cell Biochem. 2003;88:1168-1176. (Pubitemid 36397455)
39. Hurley MM, Abreu C, Harrison JR, Lichtler AC, Raisz LG, Kream BE. Basic fibroblast growth factor inhibits type I collagen gene expression in osteoblastic MC3T3-E1 cells. J Biol Chem. 1993;268:5588-5593. (Pubitemid 23090881)
40. Tanaka E, Ishino Y, Sasaki A, et al. Fibroblast growth factor-2 augments recombinant human bone morphogenetic protein-2-induced osteoinductive activity. Ann Biomed Eng. 2006;34:717-725. (Pubitemid 43824021)
41. N akamura Y, Tensho K, Nakaya H, Nawata M, Okabe T, Wakitani S. Low dose fibroblast growth factor-2 (FGF-2) enhances bone morphogenetic protein-2 (BMP-2)-induced ectopic bone formation in mice. Bone. 2005;36:399-407. (Pubitemid 40403838)
42. Minamide A, Yoshida M, Kawakami M, et al. The effects of bone morphogenetic protein and basic fibroblast growth factor on cultured mesenchymal stem cells for spine fusion. Spine. 2007;32:1067-1071. (Pubitemid 46685982)